Medicine

Senolytics target mobile senescence-- yet can they slow down growing old?

.In the 1960s, United States anatomist Leonard Hayflick noted that replicative tissues possess a restricted number of divisions, led to in part by telomere lessening and later dubbed the Hayflick restriction. He saw that some cells ceased portioning yet rejected to perish, a procedure called senescence that has considering that been actually implicated in a lot of conditions and is actually currently being targeting by biotech and pharmaceutical companies.The Medical Pipeline is actually a column on translational and clinical research, coming from bench to bedside.